Top Markets
Coin of the day
Apontis Pharma AG Apontis Pharma AG

Apontis Pharma AG

APPH
Rank in Stocks #21489
Operating within Germany, Apontis Pharma AG specializes in the marketing and... Operating within Germany, Apontis Pharma AG specializes in the marketing and distribution of pharmaceutical products, with a particular emphasis on internal medicine. The company is actively involved in the development, promotion, and commercialization of a diverse portfolio, which includes combination single-pill therapies and other medications. Key therapeutic areas of focus encompass cardiovascular diseases, such as high blood pressure (hypertension), elevated cholesterol (hyperlipidemia), and strategies for secondary prevention, in addition to respiratory ailments and diabetes. Established in 1946, Apontis Pharma AG maintains its corporate headquarters in Monheim am Rhein, Germany.
Share Price
$12.75
Last synced: 2025-11-17
Market Cap
$106.20M
Change (1 day)
-2.29%
Change (1 year)
0.24%
Country
DE
Trade Apontis Pharma AG (APPH)

Category

Earnings for Apontis Pharma AG (APPH)
Earnings in 2026 TTM: 0
According to Apontis Pharma AG latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Apontis Pharma AG from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors